AAAAAA

   
Results: 1-9 |
Results: 9
PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS
Authors: CHARNICK SB FRACASSO P EGORIN M SONNEVELD P BLEEHAN N GIACCONE G NIEDERBERGER W SMITH HT PEARCE T SIKIC BI
Citation: Sb. Charnick et al., PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF SDZ PSC-833, A NOVEL MULTIDRUG-RESISTANCE REVERSING AGENT, IN PHASE-1 TRIALS WITH CHEMOTHERAPEUTIC-AGENTS, European journal of cancer, 33, 1997, pp. 775-775
NANOSCALE GRINDING OF CERAMICS USING DIAMOND FIBERS
Authors: PARTRIDGE PG FOOKES A NICHOLSON ED PEARCE T MEADEN G
Citation: Pg. Partridge et al., NANOSCALE GRINDING OF CERAMICS USING DIAMOND FIBERS, DIAMOND AND RELATED MATERIALS, 6(5-7), 1997, pp. 893-897
CLINICAL AND COST-BENEFITS OF LAPAROSCOPIC TENCKHOFF CATHETER INSERTION FOR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD)
Authors: BANNISTER KM WATSON D PEARCE T PATERSON D
Citation: Km. Bannister et al., CLINICAL AND COST-BENEFITS OF LAPAROSCOPIC TENCKHOFF CATHETER INSERTION FOR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS (CAPD), Kidney international, 51(4), 1997, pp. 1328-1328
PHARMACOKINETIC PROFILE OF MITOGUAZONE (MGBG) IN PATIENTS WITH AIDS-RELATED NON-HODGKINS-LYMPHOMA
Authors: RIZZO J LEVINE AM WEISS GR PEARCE T KRAYNAK M MUECK R SMITH S VONHOFF DD KUHN JG
Citation: J. Rizzo et al., PHARMACOKINETIC PROFILE OF MITOGUAZONE (MGBG) IN PATIENTS WITH AIDS-RELATED NON-HODGKINS-LYMPHOMA, Investigational new drugs, 14(2), 1996, pp. 227-234
NANOSCALE DUCTILE GRINDING OF GLASS BY DIAMOND FIBERS
Authors: PARTRIDGE PG FOOKES AJ NICHOLSON ED PEARCE T MEADEN G
Citation: Pg. Partridge et al., NANOSCALE DUCTILE GRINDING OF GLASS BY DIAMOND FIBERS, Journal of Materials Science, 31(19), 1996, pp. 5051-5057
MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/
Authors: LIST AF KARANES C DORR R SPIER C GROGAN T GREER J MOORE J WEINBERGER J SCHILLER G DALTON W PEARCE T LITCHMAN M
Citation: Af. List et al., MODULATION OF ANTHRACYCLINE RESISTANCE IN POOR-RISK ACUTE MYELOID-LEUKEMIA (AML) WITH SDZ PSC-833 - RESULTS OF A PHASE I II MULTICENTER STUDY/, Blood, 88(10), 1996, pp. 1156-1156
PHASE-I STUDY OF THE CHEMOSENSITIZER SDZ PSC-833 IN COMBINATION WITH VAD CHEMOTHERAPY TO REVERSE MULTIDRUG-RESISTANCE
Authors: DALTON W GREIPP P GREENBERG P STIFF P BALLESTER O FRIEDENBERG W SALMON S KYLE R CHARNICK S PEARCE T
Citation: W. Dalton et al., PHASE-I STUDY OF THE CHEMOSENSITIZER SDZ PSC-833 IN COMBINATION WITH VAD CHEMOTHERAPY TO REVERSE MULTIDRUG-RESISTANCE, Blood, 88(10), 1996, pp. 2638-2638
PHASE-I TRIAL OF PSC-833 AND DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, AND PREDNISONE (DVCP) IN PATIENTS WITH REFRACTORY NON-HODGKINS-LYMPHOMA
Authors: COBB P BURRIS H WEISS G FIELDS S CRAIG J QUICK D COOK G PEARCE T VONHOFF D
Citation: P. Cobb et al., PHASE-I TRIAL OF PSC-833 AND DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, AND PREDNISONE (DVCP) IN PATIENTS WITH REFRACTORY NON-HODGKINS-LYMPHOMA, Blood, 84(10), 1994, pp. 10000167-10000167
NOVEL ORAL COMBINATION CHEMOTHERAPY IN THE TREATMENT OF INTERMEDIATE-GRADE AND HIGH-GRADE AIDS-RELATED NON-HODGKINS-LYMPHOMA
Authors: REMICK SC MCSHARRY JJ WOLF BC BLANCHARD CG EASTMAN AY WAGNER H PORTUESE E WIGHTON T POWELL D PEARCE T HORTON J RUCKDESCHEL JC
Citation: Sc. Remick et al., NOVEL ORAL COMBINATION CHEMOTHERAPY IN THE TREATMENT OF INTERMEDIATE-GRADE AND HIGH-GRADE AIDS-RELATED NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 11(9), 1993, pp. 1691-1702
Risultati: 1-9 |